3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
121
Lymphoid
71
Myeloid
25
Plasma cell
11
Dermatologic
5
Classical hematology
5
CNS
5
Sarcoma
4
Gastrointestinal
4
Breast
3
Other neoplasm
2
Other
2
Head & Neck
2
Gynecologic
2
Genitourinary
2
Thoracic
1
Other solid neoplasm
1
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
69
Carcinoma, Neuroendocrine
26
Pheochromocytoma
24
Thyroid Cancer, Papillary
23
Pituitary Neoplasms
21
Thyroid Neoplasms
20
Adrenocortical Carcinoma
19
Paraganglioma
16
Multiple Endocrine Neoplasia Type 1
14
Neuroblastoma
12
Adenoma, Islet Cell
11
Sarcoma
10
Neoplasms
10
Melanoma
10
Lung Neoplasms
10
Adrenal Gland Neoplasms
10
Small Cell Lung Carcinoma
9
Carcinoid Tumor
9
Adenocarcinoma, Follicular
9
Neoplasm Metastasis
8
Gastro-enteropancreatic neuroendocrine tumor
8
Carcinoma, Non-Small-Cell Lung
8
Pancreatic Neoplasms
7
Cholangiocarcinoma
7
Central Nervous System Neoplasms
7
Carcinoma, Medullary
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Thyroid Carcinoma, Anaplastic
6
Parathyroid Neoplasms
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Endocrine
×
90 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled